Gm1-Gangliosidosis, Type I, also known as beta-galactosidase-1 deficiency, is related to gm1 gangliosidosis and gm1-gangliosidosis, type ii, and has symptoms including joint stiffness An important gene associated with Gm1-Gangliosidosis, Type I is GLB1 (Galactosidase Beta 1), and among its related pathways/superpathways is Degradation pathway of sphingolipids, including diseases. The drugs Miglustat and Glycoside Hydrolase Inhibitors have been mentioned in the context of this disorder. Affiliated tissues include bone and spinal cord, and related phenotypes are decreased beta-galactosidase activity and intellectual disability